Bostwick Laboratories

The firm was counsel to the committee of unsecured creditors in the chapter 11 bankruptcy case of cancer testing firm Bostwick Laboratories. The company filed for bankruptcy protection after the lab was impacted by a decline in medical insurance reimbursements that started in 2012. In April 2017, the debtor moved forward with an auction and sale process for its assets after securing approval for its $6,300,000 stalking horse agreement.

Our website uses cookies to enhance site navigation, analyze site usage, and assist in our marketing efforts. By continuing to browse this website, you agree to our Privacy Policy.